Feb 18, 2022

Dr. Sanjoy Dutta, Ph.D. — CSO, JDRF International — Improving Lives Curing Type 1 Diabetes (T1D)

Posted by in categories: biotech/medical, government

Improving Lives Curing Type 1 Diabetes (T1D) — Dr. Sanjoy Dutta, Ph.D. — Chief Scientific Officer, JDRF

Dr. Sanjoy Dutta, PhD, is the Chief Scientific Officer at JDRF International ( a nonprofit organization that funds Type 1 Diabetes (T1D) research, provides a broad array of community and activist services to the T1D population, and actively advocates for regulation favorable to medical research and approval of new and improved treatment modalities.

Dr. Dutta oversees all of JDRF’s efforts to cure Type 1 Diabetes and improve the lives of those living with it, which includes beta cell therapies, immunotherapies, glucose control and related disease complications. He is also responsible for international partnerships with world-leading government, non-government, foundation and commercial organizations. Dr. Dutta joined JDRF in 2009.

Prior to coming to JDRF, Dr. Dutta was the Associate Director of Translational Medicine and Clinical Biomarkers at Bristol-Myers Squibb, and Principal Scientist of Cardiovascular and Metabolic Diseases at Hoffmann-La Roche.

Dr. Dutta obtained his doctorate from the department of biochemistry and molecular biology at the University of Southern California and was a JDRF Postdoctoral Fellow in the department of cell biology and the Joslin Diabetes Center at Harvard Medical School.

Comments are closed.